Feehery, CEO, stated that "Certara's second quarter performance reflected continued strength across the organization as we achieved results that were consistent with our full year outlook in both ...

Detailed price information for Eledon Pharmaceuticals Inc (ELDN-Q) from The Globe and Mail including charting and trades.